ESPR - Esperion Therap Charts, Trade Ideas, Earnings, Ratings

TRENDING : Top 50 TRCH (0%) SPY (0%) OCGN (0%) MOXC (0%) MGNI (0%) GSAT (0%) GRWG (0%) GOED (0%) GME (0%) FURY (0%) ETSY (4.21%) ENG (0%) CWH (0%) CRSR (0%) CPE (0%) CELH (0%) BZUN (0%) BFLY (0%) BBIG (0%) BA (0%) AVXL (0%) AU (0%) AMPUSD (%) AMC (0%) ABNB (0%)

ESPR - Esperion Therapeutic...

$23.42 0[0%]

15 mins delayed data

People also watch : FOLD | PFE | REGN | BMRN | ALBO | RARE

+Watchlist

3 StockHoot Traders following this.
Analyst Ratings | Earnings

Previous Close	$23.42	Open
Volume		Market Cap	684.22M
Yield		Last Dividend

Day

52 Week

NASDAQ Biotech Index is on recovery as s...	06/09/21
No summary available.

Esperion Therapeutics agrees to $18.25 m...	06/01/21
The plaintiffs in a 5-year-old lawsuit alleging securities fraud against an Ann Arbor drugmaker could get a settlement later this summer. The class ac...

Robbins Geller Rudman & Dowd LLP and Kah...	05/31/21
SAN DIEGO--(BUSINESS WIRE)--TO: ALL PERSONS AND ENTITIES THAT PURCHASED OR OTHERWISE ACQUIRED ESPERION THERAPEUTICS, INC. (ESPERION OR THE COMPANY) CO...

Esperion Therapeutics CEO steps down; CO...	05/17/21
Esperion Therapeutics Inc. has appointed Sheldon Koenig to be its new president and CEO, succeeding Tim Mayleben, who has served in the role for a dec...

Esperion Therapeutics names Sheldon Koen...	05/17/21
No summary available.

Esperion Therapeutics (ESPR) Investor Pr...	05/14/21
No summary available.

Esperion Therapeutics (ESPR) Hold Rating...	05/12/21
Stifel Nicolaus reissued their hold rating on shares of Esperion Therapeutics (NASDAQ:ESPR) in a research report report published on Tuesday morning, ...

Esperion Therapeutics (NASDAQ:ESPR) PT L...	05/11/21
Esperion Therapeutics (NASDAQ:ESPR) had its price target cut by equities researchers at Credit Suisse Group from $45.00 to $36.00 in a report issued o...

Esperion Therapeutics Inc. Shares Close ...	01/29/21
Esperion Therapeutics Inc. shares closed this week 21.4% higher than it did at the end of last week. The stock is currently up 21.1% year-to-date, do...

ANALYST RATINGS

5 analyst ratings (Last 3 months)

0.00 %

Strong Buy + Buy

Price Target (PT)

EARNINGS

Date	04/12/2019 (AMC)	Est. (EPS/Rev.)	$1.37
Actual (EPS/Rev.)	$2.5B	EPS (TTM)	$???

TRADERS TRACKING $ESPR

Service Name	Trader	% Success
Swingtrades	R. belegger	83.00 %	Follow
Alpha Swing Trades	Jonathan	68.00 %	Follow
It's only money	Gavin wells	58.00 %	Follow

SHOW ALL TRADERS

About Us

Get winning Stock, Option and Cryptocurrency trade ideas from pro-traders. Follow their strategies, see how they perform.

Product Types

Strategies

Follow Us

Secure Payments

We are not a registered investment advisor. All investments involve risk, individual's trading does not guarantee future results or returns. Investors are fully responsible for any investment decisions they make. References to specific securities should not be construed as a recommendation to buy or sell that security only mentioned for informational purposes.